PGJ2, A New Antiviral Prostaglandin: Inhibition of Sendai Virus Replication and Alteration of Virus Protein Synthesis

References

1. Alitalo K., Keski-OJA J., Vaheri A. 1981; Extracellular matrix proteins characterize human tumor cell lines. International Journal of Cancer 27:755–761
   [Google Scholar]
2. Ankel H., Mittnacht S., Jacobsen H. 1985; Antiviral activity of prostaglandin A on encephalomyocarditis virus-infected cells: a unique effect unrelated to interferon. Journal of General Virology 66:2355–2364
   [Google Scholar]
3. Benavente J., Esteban M., Jaffe B. M., Santoro M. G. 1984; Selective inhibition of viral gene expression as the mechanism of the antiviral action of PGA₁ in vaccinia virus-infected cells. Journal of General Virology 65:599–608
   [Google Scholar]
4. Crosby W. H., Forth F. W. 1956; A modification of the benzidine method for measurement of hemoglobin in plasma and urine. Blood 11:380–386
   [Google Scholar]
5. Fukushima M., Kato T., Ota K., Aray Y., Narumiya S., Hayatshi O. 1982a; Prostaglandin D₂, a potential antineoplastic agent. Biochemical and Biophysical Research Communications 105:956–964
   [Google Scholar]
6. Fukushima M., Kato T., Ota K., Aray Y., Narumiya S., Hayaishi O. 1982b; 9-Deoxy-△⁹-prostaglandin D₂, a prostaglandin D2 derivative with potent antineoplastic and weak smooth muscle-contracting activities. Biochemical and Biophysical Research Communications 109:626–633
   [Google Scholar]
7. Goodwin J. S., Webb D. R. 1980; Regulation of the immune response by prostaglandins. Clinical Immunology and Immunopathology 15:106–122
   [Google Scholar]
8. Honn K. V., Marnett L. J. 1985; Requirement of a reactive αβ-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by “A” series prostaglandins. Biochemical and Biophysical Research Communications 129:34–40
   [Google Scholar]
9. Honn K. v., Romine M., Skoff A. 1981; Prostaglandin analogs as inhibitors of tumor cell DNA synthesis. Proceedings of the Society for Experimental Biology and Medicine 166:562–567
   [Google Scholar]
10. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature; London: 227680–685
    [Google Scholar]
11. Pottathil R., Chandrabose K. A., Cuatrecasas P., Lang P. J. 1980; Establishment of the interferon-mediated antiviral state: role of fatty acid cyclooxygenase. Proceedings of the National Academy of Sciences U.S. A.: 775437–5446
    [Google Scholar]
12. Santoro M. G., Jaffe B. M. 1987; Prostaglandins and differentiation of Friend erythroleukemia cells. In Prostaglandins and Tumor Cell Proliferation and Differentiation Hammarstrom S. Edited by The Hague: Martinus Nijhoff; in press
    [Google Scholar]
13. Santoro M. G., Benedetto A., Carruba G., Garaci E. 1980; Prostaglandin A compounds as antiviral agents. Science 209:1032–1034
    [Google Scholar]
14. Santoro M. G., Carruba G., Garaci E., Jaffe B. M., Benedetto A. 1981; Prostaglandins of the A series inhibit Sendai virus replication in cultured cells. Journal of General Virology 53:75–83
    [Google Scholar]
15. Santoro M. G., Jaffe B. M., Garaci E., Esteban M. 1982a; Antiviral effects of prostaglandins of the A series: inhibition of vaccinia virus replication in cultured cells. Journal of General Virology 63:435–440
    [Google Scholar]
16. Santoro M. G., Jaffe B. M., Elia G., Benedetto A. 1982b; Prostaglandin Ai induces the synthesis of a new protein in cultured AGMK cells. Biochemical and Biophysical Research Communications 107:1179–1181
    [Google Scholar]
17. Santoro M. G., Jaffe B. M., Esteban M. 1983; Prostaglandin A inhibits the replication of vesicular stomatitis virus: effect on virus glycoprotein. Journal of General Virology 64:2797–2801
    [Google Scholar]
18. Santoro M. G., Crisari A., Benedetto A., Amici C. 1986; Modulation of the growth of a human erythroleukemic cell line (K562) by prostaglandins: antiproliferative action of prostaglandin A. Cancer Research 46:6073–6077
    [Google Scholar]